Literature DB >> 1538194

Human influenza A (H1N2) viruses isolated from China.

Y J Guo1, X Y Xu, N J Cox.   

Abstract

Reassortant influenza A viruses bearing H1 haemagglutinin and N2 neuraminidase were isolated from humans in China between December 1988 and March 1989. As primary isolation of influenza A (H1N2) viruses from humans had not been reported previously, it was of interest to determine the genetic origin of these virus isolates. The haemagglutinins of the H1N2 viruses were antigenically and genetically related to those of H1 viruses isolated world-wide since 1986, and the neuraminidases of these viruses were antigenically and genetically related to those of recent H3N2 viruses. Partial sequencing of each gene segment of three of the H1N2 viruses revealed that all gene segments except that encoding the haemagglutinin gene were derived from virus of the H3N2 subtype. Sequence differences amongst the neuraminidase, nucleoprotein and nonstructural genes of these three H1N2 reassortant viruses as well as the isolation of reassortants in seven laboratories over a 4 month period make it unlikely that the H1N2 viruses are laboratory artefacts. The spread of these reassortant viruses to other countries has not yet been documented.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1538194     DOI: 10.1099/0022-1317-73-2-383

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

Review 1.  The evolution of human influenza viruses.

Authors:  A J Hay; V Gregory; A R Douglas; Y P Lin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

2.  Matrix gene of influenza a viruses isolated from wild aquatic birds: ecology and emergence of influenza a viruses.

Authors:  Linda Widjaja; Scott L Krauss; Richard J Webby; Tao Xie; Robert G Webster
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

3.  Phenotypic expression of HA-NA combinations in human-avian influenza A virus reassortants.

Authors:  I A Rudneva; E I Sklyanskaya; O S Barulina; S S Yamnikova; V P Kovaleva; I V Tsvetkova; N V Kaverin
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

Review 4.  Pandemic threat posed by avian influenza A viruses.

Authors:  T Horimoto; Y Kawaoka
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

5.  Isolation and characterization of novel H3N1 swine influenza viruses from pigs with respiratory diseases in Korea.

Authors:  Jin-Young Shin; Min-Suk Song; Eun Ho Lee; Young-Min Lee; Seok-Yong Kim; Hyong Kyu Kim; Joong-Kook Choi; Chul-Joong Kim; Richard J Webby; Young-Ki Choi
Journal:  J Clin Microbiol       Date:  2006-08-23       Impact factor: 5.948

6.  Evaluation of a multiplex real-time reverse transcriptase PCR assay for detection and differentiation of influenza viruses A and B during the 2001-2002 influenza season in Israel.

Authors:  Musa Hindiyeh; Virginia Levy; Roberto Azar; Noemi Varsano; Liora Regev; Yael Shalev; Zehava Grossman; Ella Mendelson
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

7.  Genetic reassortment in pandemic and interpandemic influenza viruses. A study of 122 viruses infecting humans.

Authors:  L P Shu; G B Sharp; Y P Lin; E C Claas; S L Krauss; K F Shortridge; R G Webster
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

8.  Possible increased pathogenicity of pandemic (H1N1) 2009 influenza virus upon reassortment.

Authors:  Eefje J A Schrauwen; Sander Herfst; Salin Chutinimitkul; Theo M Bestebroer; Guus F Rimmelzwaan; Albert D M E Osterhaus; Thijs Kuiken; Ron A M Fouchier
Journal:  Emerg Infect Dis       Date:  2011-02       Impact factor: 6.883

Review 9.  The Ecology and Evolution of Influenza Viruses.

Authors:  Michelle Wille; Edward C Holmes
Journal:  Cold Spring Harb Perspect Med       Date:  2020-07-01       Impact factor: 5.159

10.  Influenza AH1N2 viruses, United Kingdom, 2001-02 influenza season.

Authors:  Joanna S Ellis; Adriana Alvarez-Aguero; Vicky Gregory; Yi Pu Lin; A Hay; Maria C Zambon
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.